- Iran mulls ban on vasectomies, decrease on abortions to bolster population
- CNN op-ed claims right-wingers ‘more deadly than jihadists’
- Classes resume at high school rocked by stabbings
- ABC News accuses Center for Public Integrity of stealing Pulitzer-winning work
- Law firm that cleared N.J. Gov. Christie in ‘Bridgegate’ gave 10K to RGA, which he heads
- PETA ‘hopping mad’ at Michelle Obama for using real eggs at Easter Egg Roll
- Sneaky Nebraska toddler traps self inside claw machine game
- Biden to lead $600 million work force training effort
- Atheists’ Easter taunt to Christians: ‘Jesus is a myth’
- Miley Cyrus hospitalized, cancels Kansas City show
Preemie birth preventive spikes from $10 to $1,500
ATLANTA (AP) - The price of preventing preterm labor is about to go through the roof.
A drug for high-risk pregnant women has cost about $10 to $20 per injection. Next week, the price shoots up to $1,500 a dose, meaning the total cost during a pregnancy could be as much as $30,000.
That’s because the drug, a form of progesterone given as a weekly shot, has been made cheaply for years, mixed in special pharmacies that custom-compound treatments that are not federally approved.
But recently, KV Pharmaceutical of suburban St.Louis won government approval to exclusively sell the drug, known as Makena (Mah-KEE’-Nah). The March of Dimes and many obstetricians supported that because it means quality will be more consistent and it will be easier to get.
None of them anticipated the dramatic price hike, though _ especially since most of the cost for development and research was shouldered by others in the past.
“That’s a huge increase for something that can’t be costing them that much to make. For crying out loud, this is about making money,” said Dr. Roger Snow, deputy medical director for Massachusetts’ Medicaid program.
“I’ve never seen anything as outrageous as this,” said Dr. Arnold Cohen, an obstetrician at Albert Einstein Medical Center in Philadelphia.
Doctors say the price hike may deter low-income women from getting the drug, leading to more premature births. And it will certainly be a huge financial burden for health insurance companies and government programs that have been paying for it.
The cost is justified to avoid the mental and physical disabilities that can come with very premature births, said KV Pharmaceutical chief executive Gregory J. Divis Jr. The cost of care for a preemie is estimated at $51,000 in the first year alone.
The U.S. Food and Drug Administration is not involved in setting the price for the drugs it approves.
But Snow and others said someone is going to have to pay the higher price. Some of the burden will fall on health insurance companies, which will have to raise premiums or other costs to their other customers. And some will fall on cash-strapped state Medicaid programs, which may be forced to stop paying for the drug or enroll fewer people.
“There’s no question they can’t afford this,” said Matt Salo, executive director of the National Association of Medicaid Directors.
TWT Video Picks
By returning to Christian roots, the nation can achieve greatness once again
- 'Culture of intimidation' seen in Nevada ranch standoff
- GOP writes legislation to deny Attorney General Eric Holder his salary
- Secret U.S. assessments show Afghanistan not ready to govern on own
- Fuel-filled wings, ability to swarm: Pentagon offers glimpse at future of drone fleet
- CARSON: Recovering Tocqueville's vision of American exceptionalism
- Atheists rush to stage Easter display: 'Jesus Christ is a myth'
- U.S. Navy to turn seawater into jet fuel
- Nevada Bundy ranch standoff could leave dirt on Harry Reid reputation
- EDITORIAL: Intolerance at Brandeis silences Muslim dissident Hirsi Ali
- Kirsten Dunst: Actress sparks feminist ire: 'You need a man to be a man'
Celebrity deaths in 2014
Top 10 handguns in the U.S.